Qube Research & Technologies (QRT)’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$410K Buy
259,561
+48,213
+23% +$81.3K ﹤0.01% 2789
2025
Q4
$353K Buy
+211,348
New +$366K ﹤0.01% 2904
2025
Q3
Sell
-39,036
Closed -$35.4K 3845
2025
Q2
$35.4K Buy
+39,036
New +$23.2K ﹤0.01% 3199
2024
Q3
Sell
-68,286
Closed -$68.1K 3767
2024
Q2
$68.1K Buy
68,286
+55,163
+420% +$60.9K ﹤0.01% 2676
2024
Q1
$19.4K Buy
+13,123
New +$14.9K ﹤0.01% 3698
2023
Q2
Sell
-221,946
Closed -$333K 2728
2023
Q1
$333K Buy
221,946
+84,378
+61% +$118K ﹤0.01% 1711
2022
Q4
$161K Buy
137,568
+34,246
+33% +$43.2K ﹤0.01% 1880
2022
Q3
$117K Buy
103,322
+13,362
+15% +$19.6K ﹤0.01% 1924
2022
Q2
$142K Buy
+89,960
New +$119K ﹤0.01% 1820
2021
Q2
Sell
-191,483
Closed -$450K 2560
2021
Q1
$450K Buy
191,483
+3,519
+2% +$8.45K 0.01% 1236
2020
Q4
$331K Buy
187,964
+91,260
+94% +$128K ﹤0.01% 1307
2020
Q3
$91K Sell
96,704
-38,434
-28% -$33.9K ﹤0.01% 1503
2020
Q2
$118K Buy
+135,138
New +$119K ﹤0.01% 1493

Other funds holding LCTX